MAD2L1 and neoplasm: We generated a tumor-sensitized background by crossing Cre transgenic Mad2l1f/fand FLOX-Trp53 (Trp53f) mice (Jonkers et al., 2001); Trp53 loss has been shown to promote survival of Mad2l1-deficient murine cells (Burds et al., 2005).